Residency · Residency · Oral Maxillofacial Surgery

Maxillary Sinus Augmentation

Overview

Maxillary sinus augmentation (sinus lift) is a bone grafting procedure designed to increase bone height in the posterior maxilla for implant placement. It addresses the common problem of insufficient residual bone height that results from sinus pneumatization and alveolar ridge resorption following tooth loss. Two primary approaches exist: the lateral window (direct) technique and the transcrestal (indirect/osteotome) technique. This is a predictable procedure, with implant survival rates of 90-97% in augmented sinuses.

Anatomy of the Maxillary Sinus

The maxillary sinus is the largest paranasal sinus and has a pyramidal shape. The anterior wall is the facial surface of the maxilla. The posterior wall is the infratemporal surface, where the posterior superior alveolar artery and nerve are located. The medial wall forms the lateral nasal wall and contains the natural ostium, which drains into the middle meatus via the infundibulum. The floor is formed by the alveolar and palatine processes and is intimately related to the premolar and molar roots. The roof forms the orbital floor. The sinus is lined by the Schneiderian membrane, a pseudostratified ciliated columnar epithelium that is 0.3-0.8 mm thick.

The blood supply to the lateral wall comes primarily from the posterior superior alveolar artery (PSAA), whose intraosseous branch courses within the lateral wall and is important during the lateral window approach. Bony septa (Underwood septa) are present in 31-58% of sinuses; these projections from the sinus floor divide the sinus into compartments and can complicate membrane elevation.

Indications

Sinus augmentation is indicated when residual bone height in the posterior maxilla is less than 10 mm, though the specific threshold depends on the approach used. The lateral window approach is generally employed when residual bone height is less than 5-6 mm. The transcrestal approach is used when residual bone height is 5-8 mm, though some protocols with experienced surgeons allow for as little as 3-4 mm.

Contraindications

Absolute contraindications include acute maxillary sinusitis, uncontrolled systemic disease, and a history of radiation to the maxilla. Relative contraindications include chronic sinusitis (which should be treated first), heavy smoking, sinus pathology (polyps, mucous retention cysts that need evaluation and management), prior Caldwell-Luc procedure, and immunosuppression.

Preoperative Assessment

CBCT evaluation is essential and should assess residual bone height at planned implant sites, sinus membrane thickness (thickening greater than 5 mm suggests chronic inflammation), presence and location of Underwood septa, position of the PSAA in the lateral wall (typically 15-19 mm above the crest), sinus pathology, ostium patency, and nasal septal deviation or other nasal pathology. Medical evaluation should cover sinus health history, allergies, and nasal obstruction. ENT referral is indicated if significant sinus pathology is identified preoperatively.

Lateral Window Approach (Direct Sinus Lift)

Indications

The lateral window approach is indicated when residual bone height is less than 5 mm, when significant vertical augmentation (greater than 5 mm) is needed, and for either simultaneous or staged implant placement.

Surgical Technique

Anesthesia includes posterior, middle, and anterior superior alveolar nerve blocks, a greater palatine block, and local infiltration. A crestal incision with an anterior vertical releasing incision is made, avoiding a posterior vertical release over the tuberosity due to hemorrhage risk. A full-thickness mucoperiosteal flap is reflected superiorly to expose the lateral wall of the maxilla.

A window osteotomy is created in the lateral wall using a round diamond bur, piezosurgery, or specific sinus kit burs. The superior border is placed approximately 3-5 mm below the intraosseous branch of the PSAA, and the inferior border approximately 3-5 mm above the alveolar crest. The bur is taken through the cortex until the Schneiderian membrane becomes visible as a bluish hue. Piezosurgery reduces membrane perforation risk compared with rotary instruments.

Sinus curettes are used to carefully elevate the Schneiderian membrane from the floor, medial wall, and anterior and posterior walls. Elevation begins at the inferior border and proceeds circumferentially, maintaining membrane integrity, which is key to successful graft containment. The membrane is elevated to the desired height, typically to accommodate 10-13 mm total bone height for the planned implant.

Graft material is packed beneath the elevated membrane, taking care to avoid over-packing (which can obstruct the ostium) and ensuring uniform filling without membrane displacement. A collagen membrane placed over the lateral window is controversial, with some surgeons omitting this step. The flap is closed with tension-free primary closure.

Simultaneous vs. Staged Implant Placement

Simultaneous implant placement is appropriate when residual bone height is at least 4-5 mm, providing sufficient primary stability. When residual bone height is less than 4 mm, a staged approach is used, with implants placed 6-9 months after grafting. Minimum insertion torque for simultaneous placement is 15-25 Ncm.

<image>Step-by-step surgical illustration of the lateral window sinus augmentation technique, showing the osteotomy design on the lateral maxillary wall, Schneiderian membrane elevation with sinus curettes, graft material placement, and collagen membrane coverage of the window</image>

Transcrestal Approach (Indirect Sinus Lift / Osteotome Technique)

Summers Osteotome Technique

Access is gained through the implant osteotomy site. Sequential osteotomes of increasing diameter are used to condense bone laterally (improving density in D3-D4 bone), fracture the sinus floor with controlled mallet taps, and elevate the Schneiderian membrane superiorly. Graft material is placed through the osteotomy and pushed into the sinus, and the implant is placed simultaneously.

Hydraulic Sinus Lift Variations

These techniques use hydraulic pressure (saline, PRF, or bone graft slurry) to elevate the membrane through the osteotomy, reducing the risk of membrane perforation compared with the traditional osteotome technique. Specialized kits such as the CAS-Kit, iRaise, and Densah bur system are available.

Indications

The transcrestal approach is used when residual bone height is 5-8 mm (with some experienced surgeons extending to 3-4 mm), when modest augmentation of 3-5 mm is needed, and at single or limited implant sites. It offers less invasiveness, shorter surgical time, and less postoperative morbidity than the lateral window approach, but achieves limited elevation (typically less than 5 mm), has a potentially higher membrane perforation rate (often undetected and clinically insignificant), does not allow direct visualization of the membrane, and is not suitable when significant augmentation is needed.

Graft Materials

Autogenous Bone

Autogenous bone is the biological gold standard, providing osteogenic, osteoinductive, and osteoconductive properties. Donor sites include the mandibular ramus, symphysis, iliac crest, and tibia. Disadvantages include donor site morbidity, limited volume, and variable resorption. It can be used alone or mixed with other graft materials.

Allografts

Freeze-dried bone allograft (FDBA) and demineralized freeze-dried bone allograft (DFDBA) provide osteoconductive and mildly osteoinductive properties (DFDBA retains BMPs). Allografts are the most commonly used graft material for sinus augmentation in North America and eliminate donor site morbidity.

Xenografts

Bovine-derived deproteinized bone mineral (Bio-Oss/Geistlich is the most studied) serves as an osteoconductive scaffold with very slow resorption, allowing prolonged volume maintenance. Extensive evidence supports its use in sinus augmentation. It may be used alone or mixed with autogenous bone.

Alloplasts

Synthetic materials include beta-tricalcium phosphate (beta-TCP), hydroxyapatite, and bioactive glass. These are osteoconductive only, with variable resorption rates. They are useful when other materials are unavailable or when the patient prefers a synthetic option.

rhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2)

rhBMP-2 is a potent osteoinductive agent that is FDA-approved for sinus augmentation (INFUSE/Medtronic). It eliminates the need for autogenous bone harvest. Controversy surrounds its cost, off-label use in other applications, and potential complications including excessive bone formation and membrane perforation risk.

Membrane Perforation Management

Incidence

Perforation rates for the lateral window approach range from 10-35%, while the transcrestal approach has an estimated rate of 0-25% (difficult to assess directly). Risk factors include thin membrane, presence of septa, previous sinus surgery, sharp instruments, and aggressive technique.

Classification (Fugazzotto)

Small perforations (less than 5 mm) can be managed conservatively. Medium perforations (5-10 mm) require repair. Large perforations (greater than 10 mm) may require aborting the procedure.

Repair Techniques

Small perforations are managed by folding the membrane over itself to create a double layer or by placing a resorbable collagen membrane as a patch. Medium perforations are repaired with a collagen membrane sutured or tucked under intact membrane edges, with fibrin glue as an adjunct. Large perforations are covered with a resorbable membrane if possible; if uncontrollable, the procedure is aborted and reattempted in 6-8 weeks. A thin cortical bone strip (lamellar bone) can be placed over the perforation as rigid support. PRF membranes are used as a biological barrier adjunct.

<image>Intraoperative photograph showing a Schneiderian membrane perforation during lateral window sinus augmentation, with demonstration of the collagen membrane repair technique covering the perforation before graft placement</image>

Complications

Intraoperative

Besides Schneiderian membrane perforation, complications include hemorrhage from the PSAA (controlled with bone wax, electrocautery, or pressure, and the artery may need to be ligated or cauterized within the bony canal), damage to adjacent tooth roots, and fracture of the lateral wall segment into the sinus.

Postoperative

Sinusitis occurs in 2-5% of cases, presenting with nasal congestion, purulent discharge, and pain. It is managed with antibiotics (amoxicillin/clavulanate), decongestants, and ENT referral if refractory; graft removal may be necessary if infection persists. Graft infection or loss is rare but may require surgical debridement. Benign paroxysmal positional vertigo (BPPV) can result from osteotome mallet impacts causing otolith displacement; it is usually self-limiting and treated with the Epley maneuver. Wound dehiscence with graft exposure is managed conservatively if small and surgically if large. Implant failure in augmented bone occurs at rates comparable to or slightly higher than in native bone.

Outcomes

Implant survival in augmented sinuses ranges from 90-97%, comparable to implants in native bone. The lateral window approach is well-validated with more than 20 years of long-term data. The transcrestal approach has comparable short- and medium-term outcomes. Graft maturation requires 6-9 months for the staged approach. New bone formation varies by graft material: autogenous bone shows the highest early vital bone percentage, while xenograft maintains volume longer.

Clinical Pearls

CBCT is mandatory for sinus augmentation planning and should never be replaced by a panoramic radiograph alone. Piezosurgery for the lateral window reduces membrane perforation by approximately 50% compared with rotary instruments. When a septum is present, two separate windows should be considered, one on either side of the septum. The ostium must not be blocked by graft material, so the medial wall elevation should stop short of the ostium height. Nasal decongestant spray (oxymetazoline) should be prescribed for 5-7 days postoperatively to maintain sinus drainage. Sinus precautions for 2-4 weeks include no nose blowing, sneezing with the mouth open, and no straw use. If membrane perforation occurs and is repairable, outcomes are generally similar to non-perforated cases.

References

• Boyne PJ, James RA. Grafting of the maxillary sinus floor with autogenous marrow and bone. J Oral Surg. 1980.
• Summers RB. A new concept in maxillary implant surgery: the osteotome technique. Compendium. 1994.
• Pjetursson BE, et al. Maxillary sinus floor elevation using the lateral window approach. A systematic review. J Clin Periodontol. 2008.
• Tatum OH. Maxillary and sinus implant reconstructions. Dent Clin North Am. 1986.
• Stacchi C, et al. Changes in implant stability using different site preparation techniques. Clin Implant Dent Relat Res. 2013.
• Wallace SS, Froum SJ. Effect of maxillary sinus augmentation on the survival of endosseous dental implants. Ann Periodontol. 2003.

Read this lecture as Markdown